Day 1 -Friday, 21 July 2017
Meeting category
Date(s)
21 Jul 2017 - 22 Jul 2017
Location
Paris,
France
Organizer
Platinum Level Support
Sponsor logos
International Workshop on HIV & Pediatrics 2017
Related Enduring Materials
Enduring Materials
Session 1: Pediatric Treatment and Management -
Chair
Latest Estimates for Pediatric/Adolescent HIV Prevalence and Coverage
What Have We Learned from the ACT Initiative – identifying and treating children with HIV infection
The Hidden Pediatric HIV Epidemic in Eastern Europe
Challenges and Triumphs of Pediatric HIV Care and Treatment in West/Central Africa
Debate: Integrase Inhibitor-Based ART should be First-Line Therapy for Children -
Chair
Debate: Integrase Inhibitor-based ART should be first-line therapy for children
Debate: Integrase Inhibitor-based ART should be first-line therapy for children
Oral Abstract Presentations -
Chair
Comparing Conventional to Point-of-Care (POC) Early Infant Diagnosis (EID): Pre and post intervention data from a multi-country evaluation
Virological dynamics in HIV-infected infants following very early antiretroviral treatment
Characteristics and outcomes of infants initiating early antiretroviral therapy in South Africa, 2006-2016 – The International epidemiologic Databases to Evaluate AIDS Southern Africa (IeDEA-SA) Collaboration.
Age-stratified rates of mortality and key clinical events in youth aged 0-24 years in the multiregional IeDEA network
Incidence of virological failure to first-line ART among children in Europe and Thailand
Multi-month prescription of antiretroviral therapy and its feasibility - experiences from the Baylor International Pediatric AIDS initiative (BIPAI) in six Southern African countries
Session 2: Models and Comorbidities/Coinfections -
Mark Cotton, MD, PhD
Chair
Tygerberg Children’s Hospital (TCH), Stellenbosch University (SU), South Africa
Case Management of Mycobacterial Infections/HIV -
Chair
Case Management of Mycobacterial Infections//HIV - High Resource Country
Case Management of Mycobacterial Infections//HIV - Low Resource Country
Linda Barlow-Mosha, MD, MPH
Makerere University-Johns Hopkins University Research Collaboration, Uganda
Oral Abstract Presentations -
Chair
Victor Musiime, MBChB, MMED, PhD
Makerere University, Kampala, Uganda
Structured and Culturally-Relevant Disclosure Intervention Improves Pediatric HIV Disclosure in Ghana: The SANKOFA Experience
"Growth evolution and stunting among HIV-infected adolescents in the multiregional IeDEA cohort consortium"
Structural brain changes and associations in perinatally infected younger adolescents in CTAAC
Poster Presentations -
Chair
Victor Musiime, MBChB, MMED, PhD
Makerere University, Kampala, Uganda
Structural brain changes and associations in perinatally infected younger adolescents in CTAAC
Dr. Jacqueline Hoare
-
Impacts of vitamin D and calcium supplementation on bone mineral density among perinatally HIV-infected adolescents: A 48-week randomized clinical trial
Early clinical and social outcomes at and after transfer from pediatric to adult HIV care in Asia
Endothelial dysfunction in HIV-infected children
Does HIV-Related Vascular Disease Gradually Improve with Accumulating Time on ART? Data from CHER
Day 2 - Saturday, 22 July 2017
Oral Abstract Presentations -
Chair
Pregnancy and Neonatal Outcomes following Prenatal Exposure to Dolutegravir
Intensification of antiretroviral treatment with raltegravir for late-presenting HIV-infected pregnant women
Is Tenofovir Use in Pregnancy Associated with Preterm Delivery? A Canadian Perinatal HIV Surveillance Program Analysis
Hepatotoxicity in HIV+ Postpartum Women Initiating Efavirenz-Containing Regimens
Asymptomatic Hematologic Toxicity Associated with Very Early Combination Antiretroviral Therapy (cART) in In Utero HIV-infected Infants
Oral Abstract Presentations -
Chair
The population effect of HIV exposure in HIV-uninfected children on infant mortality in Botswana and South Africa
Developmental outcomes of breastfed, HIV-exposed uninfected and breastfed, HIV-unexposed children in the context of universal maternal antiretroviral therapy: a prospective cohort
Oral Abstract Presentations -
Chair
Inequality in mortality and access to antiretroviral therapy in adolescents living with perinatally-acquired HIV in sub-Saharan Africa: a Collaborative Initiative for Paediatric HIV Education and Research (CIPHER) Cohort Collaboration analysis
Attrition and treatment outcomes among perinatally and behaviourally HIV-infected adolescents and youths in Thai National AIDS program
What constitutes adolescent-friendly health services? Clinic characteristics that attenuate internalised HIV stigma among adolescents living with HIV.
Experiences of transition to adult care and readiness to self-manage care in young people with perinatal HIV in England
Debate: Self-Testing Should be Implemented for All Adolescents -
Chair
Diana Gibb, MD, MRCP, MSc
Medical Research Council Clinical Trials Unit, England
What constitutes “Adolescent Friendly” Programming? -
Chair
Discussion: What constitutes “Adolescent Friendly” Programming?
Overview
Welcome
Over 300 participants from all over the world attended the 9th edition of the HIV Pediatrics workshop that took place on 21 - 22 July 2017 in Paris, France. With 20 Orals, 87 posters and 45 abstractbook only abstracts, we are proud to say that this was one of the most successful editions to date.
The Organizing Committee would like to thank all the invited speakers and participants for their contribution to this meeting!
We are grateful to our supporters ViiV Healthcare, Gilead, NIH, Johnson & Johnson, IMPAACT, Mylan EGPAF, ANRS, PENTA and ROCHE for making this event possible.
Language
Related Programs
